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Abstract
The serotonin transporter  (SERT) modulates  the entire serotonergic  system in the brain and 
influences  both  the  dopaminergic  and  norepinephrinergic  systems.  These  three  systems  are 
intimately involved in normal physiological functioning of the brain and implicated in numerous 
pathological  conditions.   Here we use high-resolution magnetic resonance imaging (MRI)  and 
spectroscopy to elucidate the effects of disruption of the serotonin transporter in an animal 
model system: the SERT knock-out mouse.  Employing manganese-enhanced MRI, we injected 
Mn2+ into the prefrontal cortex and obtained 3D MR images at specific time points in cohorts of 
SERT and normal mice.  Statistical analysis of co-registered datasets demonstrated that active 
circuitry originating in the prefrontal cortex in the SERT knock-out is dramatically altered, with 
a bias towards more posterior areas (substantia nigra, ventral tegmental area, and Raphé nuclei) 
directly  involved  in  the  reward  circuit.   Injection  site  and  tracing  were  confirmed  with 
traditional track tracers by optical microscopy.  In contrast, metabolite levels were essentially 
normal  in  the  SERT knock-out  by  in  vivo  magnetic  resonance  spectroscopy  and  little  or  no 
anatomical differences between SERT knock-out and normal mice were detected by MRI.  These 
findings point to modulation of the limbic cortical-ventral striatopallidal by disruption of SERT 
function.  Thus, molecular disruptions of SERT that produce behavioral changes also alter the 
functional anatomy of the reward circuitry in which all the monoamine systems are involved.
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Introduction
The serotonin transporter (SERT) regulates serotonin levels in the synaptic cleft through active 
uptake from the extracellular space (Li, 2006) and is encoded by a single gene in mouse (Bengel 
et al., 1997).  SERT is the target of a large class of psychoactive drugs used in a number of 
anxiety  disorders,  as  well  as  drugs  of  abuse  such  as  cocaine  and 
methylenedioxymethamphetamine (MDMA).  Moreover,  SERT is  the principal  regulator  of  the 
entire serotonergic system (Murphy et al., 2004) and dysregulation of SERT gene expression is 
implicated as a risk factor for a number of affective disorders  (Gainetdinov and Caron, 2003; 
Murphy et al., 2004; Murphy et al., 2001).
Mouse knock-outs for SERT and the other two monoamine transporters, dopamine transporter 
(DAT)  and  norepinephrine  transporter  (NET),  have  been  used  extensively  to  study  the 
pharmacological, behavioral, and anatomic consequences of disruption (Caron, 1999; Dykstra et 
al., 2003; Gainetdinov and Caron, 2003; Gainetdinov et al., 2002; Hall et al., 2004; Kita et al., 
2003; Numachi et al., 2007; Reith, 2005; Rocha, 2003; Torres and Caron, 2005; Uhl, 2003; Uhl et 
al.,  2002;  Xu et  al.,  2000; Yamashita et  al.,  2006).   Single  and multiple  knock-outs  of  the 
monoamine  transporters  have  been  especially  useful  in  investigations  aimed  at  linking  the 
molecular actions and behavioral consequences of drugs of abuse (Sora et al., 2001; Uhl and Lin, 
2003).  These studies have generated a wealth of information about specific aspects of these 
model  systems  at  the  molecular  level  (e.g. up/down regulation  of  monoamine receptors  in 
response to uptake inhibition, altered concentrations of monoamine metabolites  and related 
molecules), and at the behavioral level (e.g. conditioned place preference, locomotor response, 
drug induced response)  (Homberg et al., 2007; Li et al., 2003; Numachi et al., 2007; Rocha, 
2003; Shen et al., 2004).  
Here  we  explore  brain  circuitry  in  SERT  knock-out  mice  to  link  molecular  alterations  to 
anatomical  and  behavioral  observations.  SERT  knock-out  mice  exhibit  avoidance  and 
hyperarousal and are more vulnerable to stress than wild-type mice (Adamec et al. 2008). In 
addition,  SERT  mice  display  an  initial  impairment  of  food-  and  cocaine-self-administration 
(Thomsen et al. 2009).  A number of behaviors, including addiction, anxiety, aggression, and 
affective disorders such as depression, have been linked to anatomical brain regions, specifically 
the  limbic  cortical-ventral  striatopallidal  circuitry  (Berton  and  Nestler,  2006;  Everitt  and 
Robbins, 2005; Murphy and Lesch, 2008; Nelson and Trainor, 2007; Robbins and Everitt, 2002). 
The prefrontal cortex (PFC) is believed to perform executive functions in this circuit  (Berton and 
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Nestler, 2006; Robbins and Everitt, 2002) where it has been implicated in working memory, affect, 
temperament, attention, response initiation and management of autonomic control  and emotion 
(Canli et al., 2001; Groenewegen and Uylings, 2000; Groenewegen et al., 1997; Hagen et al., 
2002; Zald et al., 2002). The PFC is also densely innervated by serotonergic neurons arising in 
the  median  Raphe  nuclei  of  the  brain  stem  (Puig  et  al.,  2004).   Recent  work  in  monkey 
demonstrates that injection of Mn2+ into the PFC traces expected pathways deeper into the brain 
(Simmons et al., 2008).  How these pathways might be altered by a loss of SERT activity remains 
an open question.
Due  to  the  importance  of  the  PFC  and  its  connections,  and  the  expected  involvement  of 
serotonin  in  this  circuit,  we chose  to  exploit  the  SERT knock-out  mouse  to  probe  circuitry 
originating in the PFC with and without SERT activity. After stereotaxic injection of nanoliter 
volumes of MnCl2 into the PFC of knock-out and normal control mice, we followed the time 
course of Mn2+ uptake, transport, and accumulation over the first 24 hours post injection by 
sequential high resolution MRI.  We also employed MRS to compare metabolite levels in living 
brains of normal versus SERT knock-out mice.  After in vivo MR imaging, we fixed the brains and 
used diffusion tensor imaging to obtain additional structural  information and then processed 
them for histology and analysis by microscopy.  Co-injection of fluorescent tracer with the Mn2+ 
allowed definitive identification of the injection site, confirming its location and lack of damage 
at  the  cellular  level.  Detection  of  this  conventional  fluorescent  tracer  at  distant  sites  was 
examined to verify the MEMRI results. 
Finally, we adopted a non-biased comprehensive approach to identify all connections traced by 
Mn2+ throughout the brain after PFC injection. Whole brain MRI data sets from both genotypes at 
all time points were co-registered into the same 3D space (Kovacevic et al., 2005; Lee et al., 
2005) using a straightforward linear and nonlinear alignment (Bearer et al., 2007b; Tyszka et al., 
2006).  Image alignment allows an automated voxel-wise comparison of 3D MR images (Hammers 
et al., 2003; Kassubek et al., 2004; Lee et al., 2005; Mechelli et al., 2005; Toga and Mazziotta, 
2002).  This allows identification of those voxels with statistically significant intensity changes 
across time and between cohorts (Bearer et al., 2007b; Cross et al., 2004).  By comparing the 
intensities between one time point and the next, we detected the pathway of the Mn2+ as it 
progressed along neuronal circuits in each genotype.  This allowed us to probe changes in the 
reward/addiction circuitry (limbic cortical-ventral striatopallidal) due to loss of SERT activity.  
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Materials and Methods
Animals. Mice were obtained from Taconic Farms, Inc (Hudson, NY).  Ten serotonin transporter 
(SERT) knock-out mice (Taconic:  B6.129-Slc6a4tm1Kpl N10) and ten normal mice (C57Bl/6NTac) 
were  used  in  this  study.   Mice  were  female  between  the  ages  of  19  and  23  weeks.   All 
experiments were performed in accordance with protocols approved by the Institutional Animal Care and 
Use Committee of the California Institute of Technology.
Stereotaxic Injections. Stereotaxic injection procedure was similar to that employed by Bearer 
et al (Bearer et al., 2007b).  Mice were anesthetized by spontaneous inhalation of 1% isoflurane 
and placed in a stereotaxic frame (Kopf Instruments, Tujunga, CA).  5nl of 600mM MnCl2 with 0.5 
mg/ml  3k  rhodamine  dextran-amine  (RDA)  (Molecular  Probes/Invitrogen,  Eugene,  OR)  was 
injected unilaterally into the right prefrontal cortex (coordinates x –0.5 mm (lateral), y 1.0 mm 
(anterior-posterior  A-P with  bregma=0),  z  1.0  mm (dorso-ventral  D-V  with  brain  surface=0) 
(Paxinos  and  Franklin,  2001))  over  5  minutes  using  a  quartz  micropipette  (1mm OD quartz 
capillary pulled to approximately 80µm OD tip).  The animal then received 0.2ml glycopyrrolate 
(0.02 mg/kg) and 0.1ml dextrose (5%) subcutaneously;  with 0.2ml lactated Ringer’s  solution 
(10ml/kg)  IP.   It  was  then  immediately  placed  in  the  MR  scanner  under  0.8%  isoflurane 
anesthetic.
Preparation for ex vivo imaging. From 1 to 10 days after in vivo imaging, animals were sacrificed 
and  brains  fixed  via  transcardiac  perfusion  with  4%  paraformaldehyde  (PFA)  as  previously 
described (Tyszka et al., 2006).  After overnight rocking in 4% PFA at 4°C the mouse head was 
cleaned of skin, lower jaw, ears and cartilaginous nose tip and then rocked in 50ml 0.01% sodium 
azide in PBS for 7 days at 4°C.  The head was then transferred to a 5mM solution of gadoteridol 
(Prohance®, Bracco Diagnostics Inc, Princeton NJ) and 0.01% sodium azide in PBS and rocked for 
7 days at 4°C prior to MR imaging.
Magnetic Resonance Imaging and spectroscopy.  Each animal was scanned before the stereotaxic 
injection;  and  beginning  at  0:38±0:14,  1:20±0:14,  2:00±0:16,  2:44±0:14,  4:08±0:14,  and 
22:51±1:02 hours post injection.  Times are averages over all animals ± standard deviation.  We 
use the midpoint of each 40 minute scan as the “scan time” and for convenience call these the 1hr, 
1hr40m, 2hr20m, 3hr, 4hr20m and 24hr time points.  An 11.7T 89mm vertical bore Bruker BioSpin 
Avance DRX500 scanner (Bruker BioSpin Inc, Billerica, MA) equipped with a Micro2.5 gradient 
system was used to acquire all mouse brain images and spectroscopic data with a 35mm linear 
birdcage RF coil.  For in vivo imaging the animal’s head was secured in a Teflon stereotaxic unit 
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within the RF coil to minimize movement and aid in reproducible placement.  Temperature and 
respiration were continuously monitored during data acquisition and remained within normal 
ranges.  We employed a 3D RARE imaging sequence (Hennig et al., 1986) with RARE factor of 4, 4 
averages, TR/TEeff = 250ms/24ms; matrix size of 160x128x78; FOV 16mm x 12.8mm x 7.8mm; 
yielding 100µm isotropic voxels with 40 minute scan time.  The short TR provides T1 weighting to 
emphasize the location of the paramagnetic Mn2+, while the relatively long effective TE (24ms) 
provides T2 weighting that aids in providing contrast between different anatomical features.
All  in vivo mouse brain magnetic resonance spectroscopy (MRS) experiments were conducted 
using Point Resolved Spectroscopy (PRESS) (Bottomley, 1987) with a short echo time TE of 7.267 
milliseconds, recycle time of 2.3 seconds, a spectral width of 7KHz, 4000 data points in each 
free induction decay signal (FID), and 128 averages.  The sequence was preceded by a VAPOR 
water  suppression  module  (Tkáč  et  al.,  1999) interleaved  with  outer  volume  saturation. 
Optimized second order shimming was done with the Fastmap routine  (Gruetter, 1993) in a 5 
mm cube centered in the striatum.  The PRESS spectra  were then recorded inside a  2mm3 
volume (8 µl) at the center of the volume used for shimming.
For ex vivo imaging, two intact fixed heads were secured in a Teflon® holder and submerged in 
a  perfluoropolyether  (Fomblin®,  Solvay  Solexis,  Inc,  Thorofare,  NJ)  within  a  50ml  vial  and 
imaged.  The ambient bore temperature was maintained at 4°C by thermostatically controlled 
airflow.  Diffusion weighted images were acquired using a conventional  pulsed-gradient spin 
echo (PGSE) sequence (TR/TE = 300ms/11.9ms, 256 x 150 x 120 matrix, 25.6mm x 15mm x 12mm 
FOV, 100μm isotropic voxel size, 1 average, δ = 3ms, Δ = 5.2ms, Gd  = 1125mT/m, nominal b-
factor = 3370 s/mm2).  An optimized six point icosahedral encoding scheme (Hasan et al., 2001) 
was used for diffusion weighted acquisitions with a single un-weighted reference image for a 
total imaging time of 14.5 hours. 
Histology.  Brains were fixed in pairs (SERT/normal) at different time points (1, 2, 4, 6, 8, 11, 
12, 13, 16 and 21d) after injection to allow histologic determination of transport differences. 
After fixation and  ex vivo MR imaging, brains were dissected from the calvarium and sent to 
Neuroscience  Associates  (NSA,  Knoxville,  TN)  for  gelatin  embedding  and  serially  sectioned 
coronally at 30-35 µm.  All 20 brains were embedded in register into the same gelatin block, 
allowing review of the same location in the entire set on one microscope slide. Sections were 
collected into 24 cups sequentially, such that each cup contained every 24th section spanning 
the whole brain of all  20 individuals.  Alternate cups were selected for staining with either 
Thionine/Nissl  for  cellular  morphology,  or  for  mounting  unstained  in  anti-quench  with  DAPI 
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(Vector Lab, Burlingame, CA) to image the RDA fluorescence.  Sections were imaged on a Zeiss 
AxioImager Z1 equipped with both hallogen and mercury illumination, He43 filter cube, and 5x, 
10x, 20x, 40x, 63x and 100x neofluor objectives, Images were captured by an Axiocam HRC or 
MRM using AxioVision 4.5 software.
Image Alignment and Statistical Parametric Mapping.  Pre and post Mn2+ injection MR images were 
skull-stripped using the Brain Surface Extractor (BSE) within BrainSuite 2 (Shattuck and Leahy, 
2001) to remove all non-brain material.  Inaccuracies were corrected by manually editing the 
masks using BrainSuite 2.  After skull stripping, field inhomogeneities were corrected using the 
N3 method (Sled et al., 1998) and each was scaled to the mode of its intensity histogram (Bearer 
et al., 2007b; Kovacevic et al., 2005).  A minimum deformation target (MDT) was produced as 
described  (Kochunov  et  al.,  2001).   Briefly,  all  pre-injection  images  were  aligned  to  a 
representative individual with a 12-parameter full-affine transformation using Alignlinear (AIR 
5.2.5) (Woods et al., 1998a; Woods et al., 1998b) with the least squares with intensity rescaling 
cost function.  The resulting transformations were averaged and all pre-injection images were 
aligned to the average with a 12-parameter full-affine model.  The resulting transformations for 
each  cohort  were  averaged  and  the  pre-injection  images  were  then  warped  into  this  MDT 
common space beginning with a 2nd order 30 parameter model and ending with a 5th order 168 
parameter model using Align_warp (AIR 5.2.5).  For each sample, the post injection images were 
linearly aligned (12 parameter model) to the pre-injection image using Alignlinear, followed by 
the polynomial warp field used to transform that sample’s pre-injection image into the MDT.  All 
automated image processing was performed in the LONI Pipeline Processing Environment (Rex et 
al., 2003) using either a 32-processor Onyx 200 or 64-processor Origin 3000 supercomputer (SGI). 
This process placed all the images in the same space so that voxel-wise comparisons could be 
made among the different data sets.  Final images were blurred with a 0.3mm Gaussian kernel 
and  a  paired  Student’s  t-test,  as  implemented  in  SPM5  (Wellcome  Trust  Centre  for 
Neuroimaging, University  College  London),  was used to determine which voxels  increased in 
intensity when comparing one time point to the next.  Similar processing was used to compare 
rotationally invariant indices derived from DTI datasets, except that an unpaired Student’s t-test 
was used to compare knock-out and normal cohorts.  Parametric maps of voxels with statistically 
significant changes in intensity were created to display the results and to correlate increases 
with underlying anatomy  (Bearer et al., 2007b).  Anatomy was determined with reference to 
Hoff et al (Hof et al., 2000) and the Allen Brain Atlas (Dong, 2008) (http://www.brain-map.org/
welcome.do).   Sagittal  sections  were  typically  more helpful  than coronal  in  identifying  and 
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comparing anatomical structures in the in vivo MR images.
Tensor  Based  Morphometry.  A  deformation  field  analysis  implemented  by  Thompson  and 
coworkers  (Lepore et al., 2008) was used to analyze whether MRI scans of the SERT knock-out 
differ anatomically from normal mouse brain scans.  This approach has been used previously in 
studies of both mouse (Kovacevic et al., 2005; Ma et al., 2005; Spring et al., 2007; Verma et al., 
2005) and human (Lepore et al., 2008; May and Gaser, 2006; Perani et al., 2005; Reading et al., 
2005).  Briefly, all scans of a particular contrast (e.g. pre-injection, iDWI) were mapped into an 
MDT.  The resulting displacement field (JTJ, with J the deformation Jacobian) for each scan was 
employed in the actual analysis.  Maps of the determinant of JTJ were used in a voxel-wise 
Hotteling’s  T2 test  yielding  p-value  maps  to  gauge  statistical  differences  between  the  two 
cohorts at each voxel in the image.
Determination of relative metabolite concentrations.  For each mouse brain the spectrum of the 
relative amount of metabolites inside the experimental PRESS volume was quantified using the 
QUEST (quantitation based on quantum estimation) module  (Ratiney  et al.,  2005) available 
inside the Java Magnetic Resonance User Interface (JMRUI) package (Naressi  et al., 2001).  A 
basis set comprising nine metabolites was used to perform the fit.  To this end PRESS spectra of 
creatine,  choline,  N-acetyl  aspartate  (NAA),  taurine,  myo-inositol,  lactate,  glutamine, 
glutamate  and  gamma-amino-butyric  acid  (GABA)  were  simulated  using  the  NMR-SCOPE 
(Graveron-Demilly et al., 1993) simulation package within JMRUI.  The spin parameters (number 
of  spins,  chemical  shifts,  J-couplings)  were  obtained  from Govindaraju  (Govindaraju  et  al., 
2000).  The choice to use a simulated basis set rather than a measured one was based on recent 
results showing no statistically significant differences between estimates obtained using either 
basis set (Cudalbu et al., 2007).  Metabolite amounts obtained by the QUEST were normalized to 
creatine. 
Diffusion tensor image construction.  Reconstruction of the apparent diffusion-weighted images 
included spatial radial Gaussian filtering (0.25 voxel width) to smooth the co-registration cost-
function and improve the SNr of all subsequent calculations. The apparent diffusion tensor was 
calculated conventionally by inversion of the encoding b-matrix. The b-matrix for each diffusion 
encoding was determined by numerical simulation of the pulse sequence k-space trajectory in 
order to account for gradient cross-terms  (Mattiello et al., 1997).  Eigenvalues, eigenvectors, 
tensor trace and fractional anisotropy were calculated conventionally using built-in and custom 
Matlab functions  (The Mathworks  Inc.,  Natick MA).   The six diffusion weighted images were 
averaged to generate a high SNr isotropic diffusion weighted image (iDWI).  Diffusion tensor 
8
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT 3/18/09
images (and associated images of eigenvalue,  λi; trace, Tr(D); and fractional anisotropy, FA) 
were placed into the same space for voxel-wise comparisons using the methods outlined above 
for in vivo MR images. 
Rendering.  Visualization of the MR images and statistical parametric maps was performed with 
ResolveRT4 (Mercury Computer Systems, Inc., Hudson, NH) and MRIcro (Rorden and Brett, 2000). 
Results
Injection site location and condition
The injection sites were within a 0.3 mm radius for all 20 animals, as demonstrated in MR images 
recorded 1 hour after Mn2+ injection into the PFC (Figure 1).  The average injection site for all 20 
animals was: x (lateral) +0.45±0.16mm, y (A-P), +0.92±0.28mm, z (D-V) -0.86±0.27mm; for the 
SERT knockouts: x +0.43±0.16mm, y +0.74±0.25mm, z -0.83±0.26mm; and for the normals: x 
+0.47±0.17mm, y +1.1±0.18mm, z -0.88±0.29mm.  Co-injection of fluorescent dextran allowed 
identification  of  the  injection  site  by  histology.   We therefore  performed  a  comprehensive 
histological  analysis  of  all  20 brains  to  verify  the location  of  the injection  site,  detect  any 
morphologic evidence of injury, and validate that the injectate was delivered into the pathway 
previously identified by traditional tracers (Gabbott et al., 2005; Sesack and Pickel, 1992). The 
injection site could only be identified in 8 of 20 brains (4 normals and 4 SERT) that were fixed at 
1-8 days after injection.  At later time points, the injection site could not be identified.  In 4 of 
the 20 brains, the injection site was only identifiable by the presence of fluorescent dextran as 
no other sign could be found in our serial histologic sections, whether stained for morphology 
with DAPI or with Nissl/Thionine (Figure 2). Nor could any gliosis, an indicator of brain injury, be 
found at later time points (Figure 2).  In those brains where the injection site was identified by 
the presence of  rhodamine-dextran,  the  surrounding  tissue  showed no increased  cellularity, 
evidence of bleeding, or other damage/injury response, although the injectate did appear as a 
small droplet (50-100 µm diameter) displacing brain tissue at 1 day post injection.  The location 
of identified injection sites in the PFC matched the injection position in MR images.
In both SERT knock-out and normal mice microscopic examination of locations distant from the 
injection  site  showed  a  significant  number  of  rhodamine  positive  cells.   These  areas  were 
restricted to regions representing predicted targets in the pathway from PFC, such as the globus 
pallidus (Figure 3).
Metabolite concentrations are similar in SERT and wild-type mice
In vivo magnetic resonance spectroscopy offers a means to monitor non-invasively low molecular 
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weight  metabolite  levels  within  the  intact  brain  (Choi  et  al.,  2003;  Jansen  et  al.,  2006; 
Maudsley, 2002; Tkac et al., 2004).  In this study we determined concentrations of metabolites 
relative to creatine, which is assumed to remain constant among mice and between the two 
cohorts (Figure 4). All  spectra were recorded from a 2mm3 volume centered in the striatum 
(Figure 4B).  Although Student’s t-test statistical comparisons between the metabolite levels 
from  the  SERT  knock-out  and  normal  cohorts  indicate  that  none  of  the  metabolites  are 
statistically different at a p<0.05 level, the choline and taurine levels are different at p<0.053; 
both being larger in the SERT knock-out versus normals. 
Voxelwise Analysis detects no anatomical differences in SERT compared to normal mice 
We aligned 3D MR images of 20 living mice, 10 for each genotype, into a single 3D atlas and used 
statistical parametric mapping to compare brain structure between genotypes. Two separate 
statistical  analyses  were  performed.   In  the  first,  the  extent  of  anatomical  morphometric 
alterations  undergone by the SERT knock-out  was determined by tensor-based morphometry 
(TBM) of both in vivo and fixed MRI data sets.  Secondly, the impact of SERT knock-out on tissue 
structure  manifest  in  altered  water  diffusional  characteristic  was  determined  by  image 
alignment and statistical parametric mapping of images of FA and Tr(D) (Verma et al., 2005). 
The TBM analysis revealed that both the pre-injection in vivo scans and iDWI ex vivo scans had 
an  extremely  small  number  (less  than  0.1%  of  the  brain  volume)  of  statistically  different 
(p<0.01) voxels randomly scattered about the brain (colored areas in Figure 5). For the TBM 
analysis  all  the pre-injection data sets were mapped to the same MDT, the Jacobian of the 
deformation field calculated, and p-value maps noting statistical significance of differences in 
the deformations of the two cohorts determined.  A similar calculation was done beginning with 
the iDWI data sets measured on fixed brains. In Figure 5 green areas denote voxels that differ 
significantly between the SERT knock-out and normal mouse brain scans at p<0.01.  
After warping into the same space, an unpaired Student’s t-test was used to gauge whether the 
normal and SERT knock-out have different patterns of FA or Tr(D). No patterns of differences 
were observed with either FA or Tr(D) measurements with very few significantly different voxels 
between the brains of SERT knock-out and normal mice: 0.4% for FA and 0.2% for Tr(D) (Figure 
6). Colored voxels show the differences between the SERT knock-out and normal mouse at a 
significance level of p<0.01.  
Visualization of Mn2+ transport in the limbic system of living mice
In  contrast  to  the  results  of  spectroscopy  and  DTI  imaging,  where  little  to  no  differences 
between  SERT  knock-out  and  normal  mice  were  found,  Mn2+ accumulation  over  time  was 
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profoundly  different  in  SERT  knock-outs  compared  to  normals.  Alignment  and  a  consistent 
intensity  scaling  allowed  us  to  visually  and  computationally  follow  the  changes  due  to  the 
appearance  of  Mn2+ induced  hyperintensity  in  structures  distant  from  the  injection  site  in 
averaged co-aligned images, such as the slices shown in Figure 7. We aligned all of the SERT 
knock-out  in  vivo  MR  images,  then  at  each  time  point  averaged  the  images  from  the  10 
individual  SERT knock-out  mice.   The averaged  images  preserve  the fidelity  of  the original 
images  –  anatomical  structures  are  clear  and  distinct  (e.g. ventricles,  corpus  callosum, 
hippocampus,  internal  and  external  capsule  are  all  easily  identifiable)  (Figure  7).  Signal 
intensities  in  the  globus  pallidus  (GP)  and  substantia  nigra  (SNr)  regions  are  qualitatively 
unchanged from pre-injection to the 3 hour time point, then increase at 4 hours and increase 
again at 24 hours (Figure 7A).  Intensity measurements in a region of interest (ROI) within the GP 
ipsilateral to the injection site as a function of time after injection in averaged images from 
each time point and genotype confirm the visual assessment (Figure 7B) 
Statistical  mapping of Mn2+ tracing from PFC injection:  Profound differences  between SERT 
knock-out and normal mice
For an unbiased assessment of the whole brain, we performed automated voxel-wise statistical 
parametric mapping to determine the spatial extent of Mn2+ accumulation as a function of time 
after  injection  (Figure  8  and  Supplemental  Data).   For  clarity,  normal  and  SERT  knock-out 
cohorts are shown separately, and volumes with significant increases (p<0.025) are color coded. 
Comparisons between the earliest two time periods are shown in pure green for both the SERT 
knock-out and normal animals, while later times are displayed with increasing amounts of blue 
for the SERT knock-out and red for the normal animal. 
The injection site was readily detected in the 1hr compared to pre-injection statistical map, as 
shown in green in Figure 8.  The pure green colored regions are voxels that are significantly 
more intense immediately post injection than before injection of a small amount of Mn2+ into the 
prefrontal cortex.  As the green areas (1hr>pre) show in slice 1 of the coronal view (Figure 8A 
and 8B) and slices 3-5 of the sagittal view (Figure 8C and 8D), after the injection a spheroid of 
hyperintensity in the MR image appears, likely due to Mn2+ diffusion.  Comparison of the 1hr40m 
image data sets with those recorded at 1hr post-injection reveals no significant changes in either 
the SERT knock-outs or normal animals. 
By  2hr20m  post-injection,  Mn2+-induced  intensity  changes  had  already  progressed  from  the 
injection point to more distal locations.  Wide spread changes were already apparent at 2hr20m 
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post injection between the two genotypes. (Figure 8. 2hr20m>1hr40m).  For the SERT knock-
outs, at the most dorsal level of the injection site on the ipsilateral side only, the hyperintensity 
increase expands outward through layers 3 and 4 of the cortex (blue-green regions in Figure 8B 
slices 1 and 2, Figure 8D slices 1-3).  At 1.5mm off midline, the hyperintensity increase dips into 
the dorsal anterior portion of the caudate putamen (CP), courses across the CP and down into 
the globus pallidus (GP), bed nucleus of the stria terminalis (BST), and most rostral portion of 
the  thalamus  (TH).   These  changes  are  especially  apparent  in  the  ipsilateral  sagittal  slices 
(Figure 8D slices  1-5).  For the normal animals, we see relatively  small  isolated volumes of 
hyperintensity increase in the CP ipsilateral to the injection site and just outside the injection 
volume on the contralateral side (Figure 8A slice 1; Figure 8C slices 2, 7, 8). 
From 2hr20m to 3  hours  post-injection,  the SERT knock-outs  show additional  hyperintensity 
increase  in  the  ipsilateral  CP;  spreading  ipsilateral  to  contralateral  in  a  discontinuous  arc 
through several nuclei of the anterior TH (Figure 8B slices 2-4).  For the normal cohort, we note 
hyperintensity  increase  dorsal  to  ventral  across  the  anterior  third  of  the  ipsilateral  CP, 
connecting to the medial edge of the CP and down through the BST with a small amount in the 
paraventricular TH; and hyperintensity increase contralateral in the dorsal and mid level CP, 
medial portion of the GP, and more ventrally in the BST with small amounts in the TH and the 
nucleus accumbens (ACB).  See Figure 8A slices 3-5 and Figure 8C slices 1-4. 
From 3  hours  to  4hr20m post-injection,  the  SERT knock-outs  have additional  hyperintensity 
increase with more volume occupied in the same locations as 3hr>2hr20m statistical parametric 
map (SPM).  The arc through the TH is now broader and continuous to the contralateral GP.  For 
the normal animals, hyperintensity increases are displayed in major portions of the ipsilateral CP 
and medial portions of the GP, leading down to the BST, then into the reticular nucleus (RT) and 
central  portions  of  the  TH  with  additional  intensity  increases  in  dorsal  regions  of  the 
hypothalamus (HY).  No changes are seen contralateral to the injection site in this comparison 
(Figure 8. 4hr20m>3hr). 
Major differences in the accumulation of Mn2+ signal evolved throughout the time course of the 
experiment in both cohorts.  The extent and location of these changes become increasingly 
different  between  the  two cohorts  over  time.   Between  4hr20m and 24  hours,  widespread 
changes were seen in images from both knock-out and normal cohorts (pure red and blue in 
Figure 8).  
In the normal animals, three significant threads of hyperintensity can be identified, with none 
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extending further posterior than the TH at -2.5mm Bregma.  One thread runs from Layer 5 
cortex  at  0.5mm Bregma tracing  diagonally  back  to  the  midline  at  -1.6mm Bregma in  the 
retrospinal cortex (Figure 8A slices 2-4).  The second thread is ipsilateral to the injection site 
filling much of the CP, and large portions of the GP, ACB, and substantia innominata (SI); plus 
the claustrum (CLA) and nearby cortex.  This thread further expands to fill half the TH farthest 
from the midline (Figure 8A slices 4 and 5, 8C slices 1 and 2).  The third thread is contralateral 
to the injection site and somewhat smaller than the second thread but occupies substantially the 
same anatomy (Figure 8A slices 4 and 5, Figure 8C slice 8 and 9). 
In the SERT knock-outs by 24 hr, three distinct differences with normals become obvious. First, 
instead of distinct threads progressing from the injection site, in the knock-outs we note a more 
general spread of the hyperintensity posterior to the mid level TH with a larger volume occupied 
contiguously across the entire TH, i.e. compare the 24hr>4hr30m SPM with the 4hr20m>3hr SPM 
(Figure 8B slice 5).  Second, the enhanced region extends more ventrally to occupy much of the 
substantia nigra (SNr) both ipsilateral and contralateral to the injection site (Figure 8B slices 6 
and 7, Figure 8D slices 2 and 3), as well as the ipsilateral ventral tegmental area (VTA) (Figure 
8B slice 8, Figure 8D slice 4).  Finally, significant intensity increases are observed far posterior 
into  the  dorsal  nucleus  Raphé (DNR),  red  nucleus  (RN)  and pontine  reticular  nucleus  (PRN) 
(Figure 8B slices 9-12, Figure 8D slices 3-5).  This accumulation of Mn2+ in the posterior regions of 
the brain was not detected in normals. 
Discussion
Here we show profound differences in the neuronal circuitry caused by a genetic disruption of 
the  serotonin  transporter  in  a  mouse  model  system  using  a  panel  of  magnetic  resonance 
methods.  Both metabolite detection by MRS and anatomy by TBM and DTI demonstrated no 
detectible  differences  between  SERT  knock-out  and  normal  mice.   In  contrast,  widespread 
differences were revealed by neuronal transport of the MR contrast agent, Mn2+.  After injection 
of  Mn2+ into  the prefrontal  cortex  of  living  mice,  the classic  pathway to the limbic system 
became highlighted over 24 hours in normal mice, whereas in SERT knock-out, Mn2+-induced 
increased intensity occurred more caudally, progressing into the dorsal nuclei Raphé of the brain 
stem.  Thus by 24 hours little overlap in the highlighted anatomy between the two types of mice 
was found.  This dramatic difference in Mn2+ accumulation cannot be explained by alterations in 
metabolite levels or anatomy of the mutants.
MRS detectable metabolite levels  in  the caudate putamen of  knock-out mice are similar  to 
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normals.   Thus  neuronal  viability  (indicated  by  NAA/Cr),  excitatory  and  inhibitory  system 
integrity (indicated by Glu/Cr and GABA/Cr), membrane turnover (indicated by Cho/Cr), and 
glial volume (indicated by Tau/Cr) are not significantly different between the SERT knock-out 
and normal animal (Brian Ross, 2001; Dedeoglu et al., 2004; Hetherington et al., 1997; Lyoo and 
Renshaw, 2002; Marjanska et al., 2005; Morris, 1999; Rothman et al., 2003; Rudin et al., 1995).  
Histology also demonstrated no detectible toxic effect of the injectate containing 3 nmol of Mn2+ 
on the brain parenchyma in either genotype.  This agrees with work of Canals and coworkers 
who found a threshold  for  neuronal cell  death of 16nmol and for  astrogliosis  of  8nmol Mn2+ 
(Canals et al., 2008).  Thus differences in MEMRI delineated pathways are not due to selective 
anatomical damage by the injection in either genotype.
Tensor-based morphometry (TBM) also failed to show any gross anatomical differences between 
the two cohorts, i.e. no differences in the size or shape of structures, no missing structures, no 
cerebellar or hippocampal dysmorphism.  We used TBM to compare the SERT knock-out and the 
normal mouse brain based on in vivo pre-injection MRI and ex vivo iDWI data sets.  Thus, the 
lack of change must be viewed within the context of the limited spatial resolution (100µm) and 
contrast of the images. Histological examinations reveal that SERT knock-out mice have altered 
barrel field morphology (Persico et al., 2001) and other cellular level changes in the cortex and 
other parts of the brain (Altamura et al., 2007; Li, 2006; Persico et al., 2000a; Wellman et al., 
2007).  The  TBM  methodology  as  implemented  here  is  insensitive  to  changes  at  the  higher 
resolution used to detect these microscopic anatomical differences. 
Fractional anisotropy (FA) and the trace of the water diffusion tensor (Tr(D)) have been used to 
gain  insight  into  changes  in  white  matter  tracts  and  other  ordered  brain  structures 
(Drobyshevsky et al., 2005; Tyszka et al., 2006; Wieshmann et al., 1999).  FA and Tr(D) are two 
rotationally invariant indices derived from the diffusion tensor that provide information about 
underlying tissue characteristics  (Alexander et al., 2001; Basser, 1995; LeBihan, 1995; Mori et 
al., 2001; Papadakis et al., 1999; Pfefferbaum et al., 2000; Song et al., 2002; van Doorn et al., 
1996).  Fractional anisotropy is a scalar measure of the diffusion anisotropy (i.e. propensity of 
water to diffuse along, rather than perpendicular to, nerve bundles).  Tr(D) is a measure of the 
orientation-independent mean diffusivity of water in the tissue.  Statistical parametric maps of 
our data failed to detect any meaningful differences between FA and Tr(D) datasets from SERT 
knock-out and normal mice.  Hence the tracts and ordered structures detected by FA and Tr(D) 
are  essentially  normal  in  the  SERT knock-out.   Thus,  anatomical  differences  at  the  100µm 
resolution of this data are unlikely to contribute to the large differences in Mn2+ distribution.
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The dramatic differences in Mn2+ enhanced MR images in the SERT knock-out mice compared to 
normal  animals  were  found  both  in  the  anatomical  distribution  of  Mn2+-induced  intensity 
increases and in the time course of their appearance.  After introduction of nanoliter amounts of 
Mn2+ into the prefrontal cortex, both knock-out and normal mice displayed Mn2+ accumulation in 
the CP, GP, and thalamus; while only the knock-out showed additional accumulation further 
basal and posterior in the hypothalamus, SNr, VTA, RN, and PRNr over time.  
Mn2+ is an anterograde trans-synaptic tracer thought to be selectively taken up through Ca2+ or 
other  divalent  cation  channels  and  transported  via  fast  axonal  transport  within  neurons  to 
accumulate  at  distant  sites  in  sufficient  amounts  to  produce  significant  intensity  changes 
detected by T1-weighted MRI (Murayama et al., 2006; Silva et al., 2004; Van der Linden et al., 
2007).  Moreover, Mn2+ is an activity dependent tracer, as it is taken up by active neurons via 
voltage gated Ca2+ channels (Aoki et al., 2002; Drapeau and Nachshen, 1984; Narita et al., 1990) 
and crosses active synapses  (Bearer et al., 2007a; Pautler et al., 2003; Saleem et al., 2002). 
There is no known specificity of Mn2+ for any particular type of neuron.  Thus, the projections 
observed in this work likely arise from all neurons at the forebrain injection site, regardless of 
their  neurotransmitter  specificity.   In  this  regard,  several  cellular  level  differences  in  the 
prefrontal  cortex  have  been  observed  between  SERT  knockout  and  normal  mice,  including 
increased neuronal density, changes in layer thickness, and increased branch length in pyramidal 
neuron dendrites (Altamura et al., 2007; Persico et al., 2003; Persico et al., 2001; Wellman et 
al., 2007).  These cellular differences must modulate to some extent the initial uptake and, 
thus, could modulate the temporal distribution of Mn2+  originating in the forebrain.  Cellular 
differences due to SERT knock-out have also been noted in locations such as the somatosensory 
cortex, amygdala, hypothalamus, striatum, and dorsal Raphe (Kim et al., 2005; Li, 2006; Li et 
al., 2003; Lira et al., 2003; Persico, 2004; Persico et al., 2000b; Wellman et al., 2007).  These 
structural, cellular,  and molecular differences all  contribute to the functional differences in 
neuronal circuits in the two cohorts of mice that affect the transport/relocation of Mn2+.  This 
interpretation is consistent with other studies of SERT knock-out mice showing that they exhibit 
significant adaptive changes at the molecular/synaptic/cellular level; including region specific 
changes in various serotonin receptor densities and altered responses in other neurotransmitter 
systems (Fox et al., 2007; Kim et al., 2005; Li, 2006; Murphy et al., 2004; Murphy and Lesch, 
2008; Shen et al., 2004; Wellman et al., 2007). 
Mn2+  transport in the normal animal delineates some, but not all, of the expected connections 
between  the  neocortex  and  the  basal  ganglia  of  the  rodent  brain  (Carr  and  Sesack,  2000; 
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Gabbott et al., 2005; Paxinos, 2004).  Over the course of 3 hours, Mn2+  is transported from the 
prefrontal cortex to the caudate putamen (CP) and then onto the globus pallidus (GP), nucleus 
accumbens  (ACB),  and  thalamus  (TH).   Similar  connections  were  observed  in  the  rat  after 
stereotaxic  injection  on  Mn2+ into  the  CP  (Soria  et  al.,  2008).   By  4  hours  post-injection 
hyperintensity is seen in the bed nucleus of the stria terminalis (BST) and dorsal regions of the 
hypothalamus (HY).  We interpret the large volume of the striatum occupied in the 24hr>4hr20m 
statistical parametric map (SPM) of the normal mice to be a consequence of three factors: 1) 
continued input  from the prefrontal  cortex;  2)  transfer  among striatal  interneurons;  and 3) 
feedback  along  the  thalmo-striatal  pathway.   Likewise,  feedback  along  the  thalmo-cortical 
pathway accounts  for  highlighted  voxels  in  the  retrospinal  cortex.   We do not  observe  the 
pathways  (direct  or  indirect)  to  the  substantia  nigra  (SNr)  or  projections  to  the  ventral 
tegmental  area  (VTA)  in  these  experiments,  implying  relatively  lower  activity  of  neurons 
projecting to these locations in the normal mouse. 
Both temporal and spatial patterns of Mn2+ accumulation in the serotonin transporter knock-out 
mouse were profoundly different than those observed in the normal mouse. As noted by others, 
lifelong lack of SERT causes rearrangement of the relative concentrations and distributions of 
the various serotonin receptors (Gobbi et al., 2001; Holmes et al., 2003; Li et al., 2003; Mathews 
et al., 2004; Montanez et al., 2003; Murphy and Lesch, 2008) that are thought to lead to a loss of 
functional integration and inhibitory regulation in neural circuitry related to emotion and effects 
of drugs of abuse (Hariri and Holmes, 2006; Uhl et al., 2002).  Moreover, SERT knock-out mice 
show changes in dendritic morphology in the PFC (longer apical dendritic branches in the knock-
out) and the basolateral amygdala (greater neuronal density) (Wellman et al., 2007); as well as 
significant increases in neuronal cell density in the neocortex (Altamura et al., 2007).  Although 
neurons in the PFC are known to project to the basolateral amygdala (BLA)  (Gabbott et al., 
2005), no Mn2+ transport to the BLA from the injection site in the PFC is seen in the knock-out 
mouse and only  very  minor  amounts  in  the normal  mouse at  24 hours  after  injection.   We 
conclude from this that the PFC-BLA circuit is less robust than connections to the more medial 
structures (CP, ACB, and TH) in both the normal and SERT knock-out mice. 
If activity dependent uptake and release are dominant factors determining the Mn2+ distribution, 
then differences in the statistical parametric maps of the normal and SERT knock-out mice likely 
reflect differences in neuronal circuit activity.  At early times, we observed Mn2+ accumulation in 
the CP of SERT knock-outs well before normal mice; indicative of increased activity in the PFC 
(thus increased Mn2+ uptake) and/or more functionally dense connections between the PFC and 
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CP in SERT knock-outs as compared to normal mice.  Increased uptake of Mn2+ in the PFC of the 
SERT knock-out is  consistent with changes in dendrite morphology and cortical neuronal cell 
densities observed by others (Altamura et al., 2007; Wellman et al., 2007).  
Subsequent  connections  from the CP to the GP and TH were also found to be more active 
(and/or denser) in the SERT knock-out versus normal, as evidenced by the occurrence of Mn2+ 
induced  intensity  increases  in  GP  and  TH  of  the  SERT  knock-out  well  before  the  normal 
(appearing 2-3 hours  post-injection  in  SERT knock-out versus  3-4 hours  post-injection  in  the 
normal mice).  Although the normal animals are known to have important circuits involving the 
SNr, VTA, and DNR; no hint of Mn2+ transport to these locations was observed in the normal 
animal.  In contrast, at 24 hours post-injection we do note Mn2+ accumulation in these same 
structures in the SERT knock-out.  Thus, one or more of three conditions apply in the SERT 
knock-out when compared with the normal mouse: 1) increased uptake because of increased 
activity in neurons projecting from CP/GP to SNr/VTA/DNR and subsequent delivery of Mn2+; 2) 
more neurons projecting to these areas; and/or 3) increased dendritic uptake by neurons in 
these areas.
Mn2+ labels a well defined subset of the known projections from the PFC.  Labeled projections 
are qualitatively different in normal as compared to SERT knock-out animal.  The schematic in 
Figure 9 shows the three most striking general differences observed between the SERT knock-out 
and normal mouse: 1) connections from the PFC to the ACB are observed in normal, but not the 
SERT knock-out; 2) connections from the PFC to the VTA and SNr are observed in the SERT 
knock-out, but not the normal mouse; 3) connections in the SERT knock-out progress as far 
posterior as the dorsal nucleus Raphé and PRN, but stop mid thalamus in the normal mouse. 
Although connections from the VTA to the ACB are well known in the rodent (Carr and Sesack, 
2000; Gabbott et al., 2005; Gerfen, 2004; Sesack and Pickel, 1992), they are not observed here 
in either the normal or knock-out mice.  These findings imply that in the SERT knock-out the 
mesocortical  and  nigrostriatal  pathways  are  emphasized  at  the  expense  of  the  mesolimbic 
pathway.  Morphological changes noted by others (e.g. changes in barrel field density, neuronal 
density, and dendritic morphology) likely influence the functional responses reported by Mn2+ 
enhanced MRI.  Thus, we predict that PFC projections terminating in the SNr, VTA and PRNr will 
have different morphology in the SERT knock-out compare to the normal mouse: likely greater 
neuronal and or dendritic spine density. 
The  limbic  cortical-ventral  striatopallidal  circuitry  is  intimately  involved  in  addiction, 
aggression, and affective disorders (Berton and Nestler, 2006; Everitt and Robbins, 2005; Murphy 
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and Lesch, 2008; Nelson and Trainor, 2007; Robbins and Everitt, 2002).  The SERT knock-out 
animal model used here reflects many human traits associated with particular human SLC6A4 
variants  (Murphy  et  al.,  2004;  Murphy  et  al.,  2003;  Uhl,  2006).   We  have  employed  Mn2+ 
enhanced MRI to investigate descending neuronal projections originating in the most anterior 
part  of  this  circuit:  the  prefrontal  cortex.   Using  MRS,  TBM,  and  DTI  we  observe  similar 
metabolite  profiles,  gross  anatomy,  and  structural  characteristics  in  both  normal  and  SERT 
knock-out  mice.   MRI  provides  a  view  of  the  brain  bridging  its  cellular-molecular  and  the 
behavioral aspects.  From the mesoscopic view afforded by MRI, we observe that active circuitry 
originating in the prefrontal cortex in the SERT knock-out is biased towards more posterior areas 
(substantia nigra, ventral tegmental area, and dorsal nucleus Raphé) directly involved in the 
reward circuit pointing to specific modulation of this circuit by the altered lifelong serotonin 
tone.  As illustrated in this work, MRI can be used to link the micro level and macro level aspects 
of  animal  models  of  disease;  in  this  case  providing  important  insights  into  how  a  specific 
molecular alteration (SERT knock-out) is manifested in the complicated and critically important 
cortico-limbic circuit. 
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Figure and Table Legends
Figure 1.  Injection sites  are closely grouped within the prefrontal cortex. Location of the 
injection site is measured as the center of the hypointense region in the MR image recorded 1 
hour post–injection. In the three projections, injection sites for individual animals are shown as 
orange spheres for SERT knock-outs and gray spheres for normal mice.  Scale bar = 1mm.
Figure  2.  Injection  site  shows  minimal  injury.  All  20  brains  were  examined  by  histology. 
Examples of a section through the PFC of brains imaged by MR and then fixed for histology, 
sectioned coronally in the same block in register, and stained in parallel for Nissl/Thionine are 
shown. The brain in (A) was fixed at 2 days and (B) 16 days after injection.   At 2 days (A) an 
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apparent  needle  track  is  found  in  the  Nissl/Thionine  stained  section  and  confirmed  as  the 
injection  site  in  a  parallel  section  imaged by fluorescence  (C).   The fluorescent  tracer  has 
already traveled along neural processes into deeper regions of the brain and along the corpus 
callosum.  Higher magnification (D) reveals no hemorrhage, or evidence of inflammation at the 
injection site or along the track.  At 16 ddays (B) no histologic evidence of the injection can be 
found nor is any evidence of residual injury detected.  Bar = 500µm. 
Figure 3.  Neuronal transport of rhodamine-dextran and Mn2+ overlap in the globus pallidus  
(GP).  Panel A shows fluorescence microscopy of a coronal section through Bregma -0.3 mm in 
the  GP lateral  to  the  internal  capsule.   It  reveals  a  cluster  of  rhodamine-positive  neurons 
ipsilateral to the injection in the same normal mouse as shown in Figure 2A that was co-injected 
with Mn2+ and rhodamine-dextran, imaged by MR and fixed by perfusion 48 hr later.  Rhodamine 
dextran (red) appears as fluorescent particles in the neuronal cell bodies (insert at 2X).  Nuclei 
are stained blue with DAPI.  Note the normal neuronal morphology of the dextran-positive cells. 
Panel B shows the corresponding MR image slice from the 3D data set of the average 24-hour 
post  injection  normal  mouse  that  includes  the  images  from the mouse  shown  in  (A).  Note 
enhanced intensity in the GP.  The rectangle in the MR image corresponds to the location and 
size of fluorescence image in (A).
Figure 4. MR spectroscopy detects little difference between SERT knock-out and normal brains. 
A. Typical in vivo proton spectra from a small volume in the striatum reveal good signal-to-noise 
ratio.  Metabolite relative concentrations shown in B are determined from these spectra. B. 
Metabolite concentrations relative to creatine determined from analysis of in vivo spectroscopy 
data.  Only choline and taurine verge on being different in the SERT knock-out (knock-out – 
shaded bars) versus the normal (normal – unshaded bars) mouse.  Student’s  t-test comparison 
reveals p<0.054 (*) for these two metabolites.  Only the major peak(s) for each metabolite are 
noted. Lac: lactate, NAA: N-acetylaspartate, Glu: glutamine, Gln: glutamate, Cr: creatine, Cho: 
choline, Tau: taurine, GABA: γ-aminobutyric acid, M-Ins: myoinositol.
Figure 5. Tensor-based morphometry from in vivo 3D-RARE and isotropic diffusion-weighted  
MRI data of SERT knock-out and normal mice reveal no meaningful anatomic differences.  A and 
B show para-sagittal and coronal sections, respectively, from the average of all pre-injection 3D 
RARE  in vivo MR scans from both cohorts.  C and D show para-sagittal and coronal sections, 
respectively, from the average of all iDWI  ex vivo MR scans from both cohorts.  Green areas 
denote those voxels that differ (p<0.01) between cohorts in their transformation to the same 
canonical mouse brain.  Scale bar = 1mm.   
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Figure 6.  Statistical parametric mapping comparisons of Tr(D) and FA data of SERT knock-out 
and normal mice exhibit no meaningful differences.  A and B show para-sagittal and coronal 
sections, respectively, from the average of all Tr(D) images derived from ex vivo DTI scans from 
both cohorts.  C and D show para-sagittal and coronal sections, respectively, from the average of 
all FA images derived from ex vivo DTI scans from both cohorts. Colored areas show Student’s t-
test comparisons of the FA and Tr(D) values between the two cohorts where red implies SERT 
knock-out values are greater than normal animal values and blue less.  Only p<0.01 values are 
shown and they comprise less than 0.5% of the brain volume.  Scale bar = 1mm.
Figure 7.  Vizualization of MEMRI shows Mn2+ accumulation over time far from the injection 
site.  A. Coronal slices show Mn2+ induced hyperintensity near and far from the original injection 
site.   The  left  and  right  columns  show  slices  at  0.4mm  and  3.5mm  posterior  to  bregma, 
respectively.  Slices are derived from the averaged aligned  in vivo 3D MR images of 10 SERT 
knock-out mice.  Hyperintensity in the cortex (arrowhead – left column 2nd row) is due to Mn2+ 
passive diffusion from the injection site (Bregma +0.92mm, 0.5mm off midline, 0.9mm from 
surface),  while hyperintensity far from the injection site (e.g. GP and SNr) is  due to active 
transport and accumulation.  A sagittal slice from the pre-injection image at the bottom notes 
the locations of the slices.  Red circle in the GP notes the location of the center of volume of 
interest (VOI) used in B.  Scale bar =1mm.  GP: globus pallidus; SNr: substantia nigra.  B. Average 
intensity  in  a  0.065µl  volume  of  interest  centered  in  the  globus  pallidus  (red  circle  in  A) 
increases significantly as a function of time after injection.  Squares: SERT knock-out mice; 
diamonds: normals.  Error bars are one standard deviation. Scale bar = 1mm.
Figure  8.  Color-coded  statistical  parametric  maps  of  the  time  dependence  of  Mn2+ 
accumulation after injection in the prefrontal cortex show widespread differences between  
normal and SERT knock-out mice. A) and B) show coronal slices from normal and SERT knock-out 
mice, respectively.  In both panels coronal slices proceed anterior to posterior from upper left 
to lower right with placement as shown in the sagittal section. C) and D) show sagittal slices 
from normal  and  SERT  knock-out  mice,  respectively.  In  both  panels  sagittal  slices  proceed 
ipsilateral to contralateral of the injection site with placement as shown in the coronal section. 
Colored  areas  denote  those  regions  with  significant  (p<0.025)  intensity  change  between 
consecutive  time  points  indicating  Mn2+ tracing  to  those  locations.  The  1  hour  versus  pre-
injection comparison is shown in pure green for both the SERT knock-out and normal animals, 
while later times are displayed with increasing amounts of blue for the SERT knock-out and red 
for the normal animal. The average pre-injection MR image is show as grayscale background. 
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Figure 9.  Overview of difference in Mn2+ accumulation between SERT knock-out and normal 
mice.  A) Side view of increase in Mn2+ hyperintensity at 24hr compared to 4hr20m post injection 
with normal animals shown in red, SERT knock-out shown in blue, injections site is shown as a 
brown sphere, and gray semi-transparent background is the average normal animal brain.  B) 
Schematic of circuitry delineated by Mn2+ tract tracing shows significant differences between the 
normal animal and the SERT knock-out.  In B) the red arrows denote pathways highlighted in the 
normal animal, which include the nucleus accumbens (ACB) and extend only as far posterior as 
the mid thalamus (TH).  Blue arrows denote pathways highlighted in the SERT knock-out, which 
include the ventral tegmental area (VTA) and extend as far posterior as the pontine reticular 
nucleus (PRNr).  Basil nuclei of the stria terminalis: BST; caudate putamen: CP; hypothalamus: 
HY; prefrontal cortex: PFC; red nucleus: RN; substantia nigra: SNr; substantia innominata: SI. 
Table 1.  Anatomical features highlighted by Mn2+ MRI as a function of time after injection into 
the prefrontal  cortex.   Anatomical  features  were  identified  by comparing images like those 
shown in Figure 8 with standard mouse brain atlases ((Hof et al., 2000) and the Allen Brain Atlas 
(Dong,  2008)).   Sagittal  sections  were  typically  more  helpful  than  coronal  in  identifying 
anatomical structures in the in vivo MR images.  KO: SERT knock-out; N: normal control; no 
subscript: ipsilateral; IC subscript: ipsilateral & contralateral.
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Table 1.
Time after injection when change observed
Anatomical feature 1hr 1hr40m 3hr 4hr20m 24hr
PFC: prefrontal cortex KO & N
cortex KO & N
CP: caudate putamen KO & N KO & Nic KO & N Nic
GP: globus pallidus KO KOic& N KOic KO & Nic
TH: Thalamus KO KOic KO & N KOic & Nic
ACB: nucleus accumbens N Nic
Hypothalamus LHA KO
Hypothalamus DMH N KO
SI: substantia innominata Nic
SNr: substania nigra KOic
VTA: ventral tegmental area KO
RN: red nucleus KO
PRN: pontine reticular nucleus KO
DNR: dorsal nucleus Raphé KO
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